Answers are grounded in this paper and cite their sources.
Cevdet Ozdemir: 1. Assistant Editor of Allergy (European Journal of Allergy and Clinical Immunology). 2. European Academy of Allergy and Clinical Immunology (EAACI) Allied Health & Primary Care Section Chair. Elif Karakoc-Aydiner: European Academy of Allergy and Clinical Immunology (EAACI) Immunodeficiencies Working Group Member. All other authors declare no conflicts of interest. This manuscript presents a clinically oriented algorithm derived from previously published evidence; no original data were generated or analyzed. Table S1: Characteristics and comparison of immunoglobulin products. Table S2: Immunoglobulin replacement therapy-related adverse events, risk factors, and mitigation strategies. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Altunbaş et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: